Central Pharmaceutical JSC No. 3

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000DP36
VND
63,000.00
200 (0.32%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
1,31,632.48
1,20,227.68
94,243.65
91,902.24
1,16,175.93
95,223.92
1,02,431.17
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,31,632.48
1,20,227.68
94,243.65
91,902.24
1,16,175.93
95,223.92
1,02,431.17
Raw Material Cost
48,669.94
39,231.54
32,198.76
31,882.70
40,890.60
34,958.48
35,197.88
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
22,597.42
0.00
10,475.20
17,044.12
10,512.34
14,100.69
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
230.15
169.56
296.06
64.80
0.00
0.00
76.76
Selling and Distribution Expenses
50.87
53,909.02
29,754.39
31,541.34
19,716.35
33,975.86
37,984.31
Other Expenses
-23.01
-2,276.70
-29.61
-1,054.00
-1,704.41
-1,051.23
-1,417.74
Total Expenditure (Excl Depreciation)
48,720.81
93,140.56
61,953.15
63,424.04
60,606.95
68,934.33
73,182.19
Operating Profit (PBDIT) excl Other Income
82911.7
27087.1
32290.5
28478.2
55569
26289.6
29249
Other Income
10,616.87
2,001.50
8,921.67
1,588.21
7,116.75
651.15
5,976.81
Operating Profit (PBDIT)
93,528.53
34,058.54
41,116.52
32,472.98
65,546.44
29,456.56
38,358.22
Interest
230.15
169.56
296.06
64.80
0.00
0.00
76.76
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
82,962.54
80,996.14
62,044.89
60,019.53
75,285.33
60,265.45
67,233.29
Depreciation
0.00
5,047.82
0.00
2,513.06
2,860.71
2,695.71
3,425.19
Profit Before Tax
93,298.39
28,841.17
40,820.47
29,895.12
62,685.73
26,760.85
34,856.27
Tax
18,724.04
5,817.60
8,721.26
6,030.88
12,593.16
5,456.83
7,123.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
74,574.35
23,023.57
32,099.21
23,864.24
50,092.56
21,304.02
27,733.27
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
74,574.35
23,023.57
32,099.21
23,864.24
50,092.56
21,304.02
27,733.27
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
74,574.35
23,023.57
32,099.21
23,864.24
50,092.56
21,304.02
27,733.27
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
Reserves
6,07,942.26
5,33,367.91
5,10,344.34
5,42,744.93
5,18,880.70
4,68,788.13
4,47,484.11
Earnings per share (EPS)
0.0
1070.87
1492.99
1109.97
2329.89
990.89
1289.92
Diluted Earnings per share
0.0
1070.87
1492.99
1109.97
2329.89
990.89
1289.92
Operating Profit Margin (Excl OI)
62.99%
22.47%
34.16%
30.87%
47.83%
27.42%
28.27%
Gross Profit Margin
70.88%
28.19%
43.31%
35.26%
56.42%
30.93%
37.37%
PAT Margin
56.65%
19.15%
34.06%
25.97%
43.12%
22.37%
27.08%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is 9.49% vs 27.57% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is 223.90% vs -28.27% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 158.64% vs -0.43% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is 35.67% vs -42.72% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of Central Pharmaceutical JSC No. 3 With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(VND)
Change(%)
Net Sales
1,31,632.48
6,75,765.96
-5,44,133.48
-80.52%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,31,632.48
6,75,765.96
-5,44,133.48
-80.52%
Raw Material Cost
48,669.94
2,84,643.41
-2,35,973.47
-82.90%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
80,433.08
-80,433.08
-100.00%
Power Cost
0
0
0.00
Manufacturing Expenses
230.15
2,107.22
-1,877.07
-89.08%
Selling and Distribution Expenses
50.87
2,97,553.82
-2,97,502.95
-99.98%
Other Expenses
-23.01
-8,254.03
8,231.02
99.72%
Total Expenditure (Excl Depreciation)
48,720.81
5,82,197.23
-5,33,476.42
-91.63%
Operating Profit (PBDIT) excl Other Income
82,911.67
93,568.73
-10,657.06
-11.39%
Other Income
10,616.87
3,619.13
6,997.74
193.35%
Operating Profit (PBDIT)
93,528.53
1,20,577.31
-27,048.78
-22.43%
Interest
230.15
2,107.22
-1,877.07
-89.08%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
82,962.54
3,91,122.55
-3,08,160.01
-78.79%
Depreciation
0.00
23,389.45
-23,389.45
-100.00%
Profit Before Tax
93,298.39
95,080.64
-1,782.25
-1.87%
Tax
18,724.04
16,781.92
1,942.12
11.57%
Provisions and contingencies
0
0
0.00
Profit After Tax
74,574.35
52,993.75
21,580.60
40.72%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
74,574.35
52,993.75
21,580.60
40.72%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
10,294.37
-10,294.37
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
74,574.35
63,288.12
11,286.23
17.83%
Equity Capital
0
0
0.00
Face Value
10,000.00
10,000.00
0.00
Reserves
6,07,942.26
14,95,254.68
-8,87,312.42
-59.34%
Earnings per share (EPS)
0.00
1,278.48
-1,278.48
-100.00%
Diluted Earnings per share
0.00
1,278.48
-1,278.48
-100.00%
Operating Profit Margin (Excl OI)
62.99%
13.85%
0.00
49.14%
Gross Profit Margin
70.88%
17.53%
0.00
53.35%
PAT Margin
56.65%
7.84%
0.00
48.81%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 13,163.25 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 9.49% vs 27.57% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 13.30% vs 18.55% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 7,457.43 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 223.90% vs -28.27% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 48.87% vs -0.88% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 8,291.17 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 158.64% vs -0.43% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 41.90% vs -0.99% in Dec 2024

Quarterly - Interest
Interest 23.01 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 35.67% vs -42.72% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 0.00% vs -100.00% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 62.99%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024